FEXI 12
Oral fexinidazole dosing regimens for the treatment of adults with chronic indeterminate Chagas disease

- Duración
- 04/10/2017 - 31/12/2018
- Coordinador
- Joaquim Gascon
- Financiadores
- DNDi
Phase 2 Randomized, Multicenter, Double-blinded Safety and Efficacy Study
The general objective of this clinical trial is to determine the efficacy and safety of alternative dosing regimens of FEXI in reducing and clearing T. cruzi parasitemia in adult individuals with the chronic indeterminate Chagas Disease, in comparison to historical placebo control.
This is a double-blind, randomized, prospective, comparative, pharmacokineticpharmacodynamic, and proof-of-concept trial design, with three-parallel groups and historical placebo control. The trial will be conducted in 5 different sites in Spain. The trial will be sufficiently powered to compare the efficacy and safety of each of the dosing regimens of FEXI with historical placebo control. Efficacy and safety will be monitored by an external independent Data Monitoring Committee (DMC) on an ongoing basis. The committee is to include cardiac and liver safety experts, as well as Chagas Disease clinical expertise.
The total duration of patient trial participation will be approximately 14 months.
Nuestro equipo
PI
- Joaquim Gascon Research Professor, Director de la Iniciativa de Chagas y del programa de Chagas y Enfermedades Parasitarias e Importadas
ISGlobal team
- Maria Jesús Pinazo Assistant Research Professor
- Carme Subirà Biosca
- Alba Abras Postdoctoral Fellow
- Julio Alonso Assistant Research Professor
- Irene Losada Galván
- Glady Carranza Rivera
Otros proyectos
Ver proyectos pasadosNHEPACHA
Nuevas Herramientas para el Diagnóstico y la Evaluación del Paciente con Enfermedad de Chagas
Euroleish.net
Control of Leishmaniasis. From bench to bedside and community
GREPIMER
Grup de recerca en patología importada i malaties emergents i re-emergents
Diagnóstico y tratamiento del zika, dengue y chikunguña
Investigación aplicada al diagnóstico y tratamiento de los virus Zika, Dengue y Chikunguña
TcONTROL
Biomarcadores inmunológicos antígeno-específicos (células T) asociados al control de la infección por T. cruzi
XStrategy
Modelo y Herramienta para la construcción de estrategias para el incremento de la atención en Chagas
STOP
Towards the interruption of transmission of soil-transmitted helminths
TESEO
Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas
Datos de salud en población migrante
Mejora del sistema de recogida de datos de salud, en el marco del programa de atención sanitaria a la población migrante en Nador (Marruecos)
AVATAR
Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.